SEC Comment Letter 0000000000-24-004414 to iBio, Inc. (IBIO)
iBio, Inc.
Date: April 22, 2024 · CIK: 0001420720 · Accession: 0000000000-24-004414
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-278729
Letter
United States securities and exchange commission logo April 22, 2024 Felipe Duran Chief Financial Officer iBio, Inc. 8800 HSC Parkway Bryan, Texas 77807 Re:iBio, Inc. Registration Statement on Form S-3 Filed April 16, 2024 File No. 333-278729 Dear Felipe Duran: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jimmy McNamara at 202-551-7349 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Leslie Marlow
Show Raw Text
United States securities and exchange commission logo
April 22, 2024
Felipe Duran
Chief Financial Officer
iBio, Inc.
8800 HSC Parkway
Bryan, Texas 77807
Re:iBio, Inc.
Registration Statement on Form S-3
Filed April 16, 2024
File No. 333-278729
Dear Felipe Duran:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jimmy McNamara at 202-551-7349 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Leslie Marlow